Tanaka et al. studied HER2 overexpression in the rare skin condition extramammary Paget’s disease (EMPD), demonstrating that HER2 is overexpressed in aggressive EMPD cases with lymph node metastasis. Here, ERBB2 is linked to metastatic malignant neoplasm in the lymph nodes.